You’ve submitted your medical school application, what's next?

After completing your primary application through AMCAS, keep an eye on your inbox! Selected individuals will be invited to complete a secondary application.

While you wait, see recommended interview prep from the AAMC.

Applicant FAQs after submitting your medical school application

We have a rolling admissions process, which means that every applicant’s timeline is different. As long as you haven’t received a decision, you are still in consideration as an applicant. It may be helpful to refer to our admissions timeline for a general overview of the year; however, your personal journey in the admissions process may fall outside of these guidelines. Please note, that we are unable to give timeline expectations outside of the general admissions timeline.

No, we do not consider letters of intent.

No, we only consider official letters of recommendation submitted through your AMCAS application. Any follow-up letters or messages to admissions will not be considered.

Due to our extremely high number of applicants, we cannot offer individualized application feedback. However, you are welcome to join our open Virtual Office Hours to ask your questions to our admissions team. 

We use a holistic review process

The David Geffen School of Medicine uses a holistic process to review applications for admission. All medical school applications received are reviewed and select applicants are invited to submit a secondary institutional application. Following a comprehensive holistic review of both the medical school application and secondary application, select applicants are then invited to interview. Final offers of admission are determined by the Admissions Committee.

Offers of admission will be extended during the Fall and Spring following application submission and review. Two reapplications per applicant is permitted. The admissions process adheres to the AAMC's recommended Application and Acceptance Protocols as well as the school's Statement of Diversity.